Posted On: 09/28/2015 3:42:53 PM
Post# of 30066
Re: Daveludlow #20499
I don't post much but today I will give my opinion. I still shares at .07 before the RS and I'm holding them till the end at this point. I have sold all the rest and put the money to work elsewhere. I still believe the company will go forward big time in 3 - 5 years.
Lympro still has good potential but selling it is tied to getting into new trials. You can't change the testing during the middle of a trial because the test procedure has to be approved by the FDA before the trial starts. I don't know if GC didn't know that or if he just neglected to mention it in his plan.
If I had more money to buy and sit for 3 - 5 years I would at these prices, but I don't and I would wait until it goes lower and it will. That's because for now dilution is the only source of income to keep everything going.
Diagnostics Dividion will grow and either generate income or be sold. Theurueputics will continue testing and eventually be passed by what I see. MANF may well be a home run; in five years...
I still believe GC will continue to try to rescue his dad's work unless it breaks him and I believe he has developed a thick skin and continues to learn on the job.
Summarize my opinion, if you are down as far as me, cover your eyes and hold, you have money to put in a long term biotech startup buy more, otherwise you will just have to make up your mind and remember that bashing doesn't help with future buyers or your own sanity, anyways it's just money...
Lympro still has good potential but selling it is tied to getting into new trials. You can't change the testing during the middle of a trial because the test procedure has to be approved by the FDA before the trial starts. I don't know if GC didn't know that or if he just neglected to mention it in his plan.
If I had more money to buy and sit for 3 - 5 years I would at these prices, but I don't and I would wait until it goes lower and it will. That's because for now dilution is the only source of income to keep everything going.
Diagnostics Dividion will grow and either generate income or be sold. Theurueputics will continue testing and eventually be passed by what I see. MANF may well be a home run; in five years...
I still believe GC will continue to try to rescue his dad's work unless it breaks him and I believe he has developed a thick skin and continues to learn on the job.
Summarize my opinion, if you are down as far as me, cover your eyes and hold, you have money to put in a long term biotech startup buy more, otherwise you will just have to make up your mind and remember that bashing doesn't help with future buyers or your own sanity, anyways it's just money...
(0)
(0)
